Kayce Hoover
Nurse Practitioner · Indian Land, SCNPI 1821649989
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 416 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 416 payments — averaging $16.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$919
- Lilly USA, LLC$725
- Bayer$624
- AbbVie$542
- Pfizer$421
- AstraZeneca$371
- plus $3K from 31 others
What the payments were for
- Food & beverage$6,754100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 84 | $919 |
| Lilly USA, LLC | 42 | $725 |
| Bayer | 46 | $624 |
| AbbVie | 33 | $542 |
| Pfizer | 24 | $421 |
| AstraZeneca | 18 | $371 |
| Merck | 20 | $320 |
| Amgen | 16 | $317 |
| Esperion Therapeutics, Inc. | 14 | $243 |
| Boehringer Ingelheim | 12 | $242 |
| Exact Sciences | 12 | $213 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $206 |
| Amarin Pharma, Inc. | 12 | $195 |
| Astellas Pharma US Inc | 10 | $194 |
| Abbott | 2 | $128 |
| Mylan Specialty L.p. | 6 | $109 |
| Kowa Pharmaceuticals America, Inc. | 7 | $105 |
| Sanofi-aventis U.S. LLC | 5 | $97 |
| Novartis | 5 | $92 |
| Dexcom, Inc. | 5 | $90 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $88 |
| GSK | 5 | $74 |
| Biohaven Pharmaceuticals, Inc. | 4 | $73 |
| Sumitomo Pharma America, Inc. | 3 | $57 |
| Cequr Corporation | 1 | $39 |
| Shield Therapeutics Inc | 2 | $38 |
| Idorsia Pharmaceuticals US Inc | 2 | $36 |
| Edwards Lifesciences | 1 | $31 |
| Medtronic | 1 | $27 |
| Genentech USA, Inc. | 3 | $26 |
| Johnson & Johnson | 1 | $26 |
| Acerus Pharmaceuticals Corporation | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Bausch Health US, LLC | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Ardelyx, Inc. | 1 | $14 |
| Corcept Therapeutics | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,761 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 23 | $42,829 |
| TrulicityDulaglutide | 12 | $13,251 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $12,833 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $2,259 |
| Atorvastatin Calcium | 152 | $1,215 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 42 | $977 |
| Fluticasone Propionate | 68 | $943 |
| Duloxetine Hcl | 33 | $867 |
| Metoprolol Succinate | 51 | $782 |
| Levothyroxine Sodium | 85 | $652 |
| Rosuvastatin Calcium | 82 | $631 |
| Omeprazole | 57 | $628 |
| Fluoxetine Hcl | 15 | $618 |
| Losartan Potassium | 59 | $552 |
| Amlodipine Besylate | 82 | $536 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $919 | $42,82923 claims |
| Lilly USA, LLCTrulicity | $725 | $13,25112 claims |
| AstraZenecaBreztri Aerosphere | $371 | $12,83314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.
Other nurse practitioner in Indian Land
- David WiltGreenville$90K
- Whitney ReedCharleston$54K
- Mary JohnsonCharleston$34K
- Amanda HareCharleston$30K
- Kellie McLainCharleston$28K
- Colleen BoydSummerville$21K
- Mae BurtonGreenville$21K
- Melissa BramanteColumbia$19K
- Gail KirbyGreer$18K
- Alissa StrojnyMyrtle Beach$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.